EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer - Aix-Marseille Université Access content directly
Journal Articles Cancer Letters Year : 2014

EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer

Domains

Cancer
No file

Dates and versions

hal-03623754 , version 1 (29-03-2022)

Identifiers

Cite

François Bertucci, Pascal Finetti, Patrice Viens, Daniel Birnbaum. EndoPredict predicts for the response to neoadjuvant chemotherapy in ER-positive, HER2-negative breast cancer. Cancer Letters, 2014, 355 (1), pp.70-75. ⟨10.1016/j.canlet.2014.09.014⟩. ⟨hal-03623754⟩

Collections

CNRS UNIV-AMU CRCM
6 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More